Correlation Between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis Treated with Ustekinumab
Monitoring of biological treatment efficacy for psoriasis is based on clinical evaluation and patient’s quality of life. However, long-term correlation between Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI) in real life has not been studied in patients treated wit...
Main Authors: | Jeanette Halskou Hesselvig, Alexander Egeberg, Nikolai Dyrberg Loft, Claus Zachariae, Kristian Kofoed, Lone Skov |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Journals Sweden
2017-12-01
|
Series: | Acta Dermato-Venereologica |
Subjects: | |
Online Access: |
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-2833
|
Similar Items
-
Sex Differences in Dermatology Life Quality Index (DLQI) among Patients with Psoriasis
by: Mikkel Bak Jensen, et al.
Published: (2024-12-01) -
Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis
by: Julia-Tatjana Maul, et al.
Published: (2024-03-01) -
Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01) -
The combined using of ustekinumab and narrow-band phototherapy in treatment of severe psoriasis
by: Kruglova L.S., et al.
Published: (2015-09-01) -
Psoriasis: Correlation between severity index (PASI) and quality of life index (DLQI) based on the type of treatment
by: Ali Al Raddadi, et al.
Published: (2016-01-01)